Genetic Risk Score Predictive of the Plasma Triglyceride Response to an Omega-3 Fatty Acid Supplementation in a Mexican Population.
Détails
Télécharger: 30934900_BIB_D43D1CAA86D0.pdf (571.95 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_D43D1CAA86D0
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Genetic Risk Score Predictive of the Plasma Triglyceride Response to an Omega-3 Fatty Acid Supplementation in a Mexican Population.
Périodique
Nutrients
Statut éditorial
Publié
Date de publication
03/2019
Volume
11
Numéro
4
Langue
anglais
Résumé
Our group built a genetic risk score (GRS) of the plasma triglyceride (TG) response to an omega-3 (n-3) fatty acid (FA) supplementation in Caucasian Canadians that explained 21.53% of the TG variance. The objective was to refine the GRS by fine mapping and to test its association with the TG response in young Mexican adults. A total of 191 participants underwent a 6-week n-3 FA supplementation providing 2.7g/day of docosahexaenoic and eicosapentaenoic acids. Using quantitative polymerase chain reaction (PCR), 103 single-nucleotide polymorphisms (SNPs) were genotyped. A stepwise regression adjusted for age, sex, and body mass index (BMI) was used to select the strongest SNPs to include in the genetic risk model. A GRS was calculated from the sum of at-risk alleles. The contribution of the GRS to the TG response was assessed by ANCOVA with age, sex, and BMI included in the model. Several differences in allele frequency were observed between Canadians and Mexicans. Five lead SNPs were included in the genetic risk model, in which the GRS accounted for 11.01% of the variance of the TG response (p < 0.0001). These findings highlight the important contribution of genetic factors to the heterogeneity of the TG response to an n-3 FA supplementation among Mexicans.
Mots-clé
Genotype, Humans, Male, Adult, *Genetic Predisposition to Disease, *Polymorphism, Single Nucleotide, Dietary Supplements, Fatty Acids, Omega-3/*administration & dosage/*pharmacology, genetic risk score, Mexico, nutrigenetics, omega-3 fatty acids, Risk Factors, triglycerides, Triglycerides/*blood, Young Adult
Pubmed
Création de la notice
19/02/2020 12:23
Dernière modification de la notice
29/04/2021 14:37